Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details

Comments

Results of the Ticlid or Plavix Post-Stents (TOPPS) trial: do they justify the switch from ticlopidine to clopidogrel after coronary stent placement?

Peter B Berger email

Current Controlled Trials in Cardiovascular Medicine 2000, 1:83-87doi:10.1186/cvm-1-2-083

No comments have yet been made on this article

Post a comment

Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2008 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.